These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maryland
|
52-1975978
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
2303 Dulles Station Boulevard
Herndon, VA
|
20171
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
x
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
Unaudited Condensed Consolidated Balance Sheets at December 31, 2012 and March 31, 2013
|
3
|
|
Unaudited Condensed Consolidated Statements of Income for the three months ended March 31, 2012 and 2013
|
4
|
|
Unaudited Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2012 and 2013
|
4
|
|
Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2012 and 2013
|
5
|
|
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and 2013
|
6
|
|
7
|
|
|
|
16
|
|
|
19
|
|
|
19
|
|
PART II — OTHER INFORMATION
|
|
|
Item 1. Legal Proceedings
|
20
|
|
Item 1A. Risk Factors
|
20
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
20
|
|
Item 3. Defaults Upon Senior Securities
|
20
|
|
Item 5.
Other Information
|
20
|
|
Item 6. Exhibits
|
21
|
|
SIGNATURES
|
22
|
|
CERTIFICATIONS
|
|
December 31,
2012
|
March 31,
2013
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 47,517 | $ | 50,762 | ||||
|
Tuition receivable, net of allowances for doubtful accounts of $6,596 and $6,476 at December 31, 2012 and March 31, 2013, respectively
|
23,262 | 22,181 | ||||||
|
Income taxes receivable
|
4,454 |
─
|
||||||
|
Other current assets
|
14,422 | 12,052 | ||||||
|
Total current assets
|
89,655 | 84,995 | ||||||
|
Property and equipment, net
|
121,520 | 117,912 | ||||||
|
Deferred income taxes
|
3,279 |
─
|
||||||
|
Goodwill
|
6,800 | 6,800 | ||||||
|
Other assets
|
6,538 | 6,320 | ||||||
|
Total assets
|
$ | 227,792 | $ | 216,027 | ||||
|
LIABILITIES & STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 39,124 | $ | 31,082 | ||||
|
Income taxes payable
|
─
|
4,700 | ||||||
|
Unearned tuition
|
494 | 229 | ||||||
|
Other current liabilities
|
281 | 281 | ||||||
|
Current portion of term loan
|
3,125 | 3,125 | ||||||
|
Total current liabilities
|
43,024 | 39,417 | ||||||
|
Term loan, less current portion
|
121,875 | 121,094 | ||||||
|
Other long-term liabilities
|
21,905 | 23,193 | ||||||
|
Total liabilities
|
186,804 | 183,704 | ||||||
|
Commitments and contingencies
|
||||||||
|
Stockholders’ equity:
|
||||||||
|
Common stock, par value $0.01; 20,000,000 shares authorized; 11,387,299 and 10,810,872 shares issued and outstanding at December 31, 2012 and March 31, 2013, respectively
|
114 | 108 | ||||||
|
Additional paid-in capital
|
299 | 377 | ||||||
|
Retained earnings
|
41,311 | 32,435 | ||||||
|
Accumulated other comprehensive income (loss)
|
(736 | ) | (597 | ) | ||||
|
Total stockholders’ equity
|
40,988 | 32,323 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 227,792 | $ | 216,027 | ||||
|
For the three months
ended March 31,
|
||||||||
|
2012
|
2013
|
|||||||
|
Revenues
|
$
|
149,532
|
$
|
137,506
|
||||
|
Costs and expenses:
|
||||||||
|
Instruction and educational support
|
73,764
|
73,427
|
||||||
|
Marketing
|
15,469
|
17,721
|
||||||
|
Admissions advisory
|
6,793
|
5,351
|
||||||
|
General and administration
|
12,648
|
11,088
|
||||||
|
Total costs and expenses
|
108,674
|
107,587
|
||||||
|
Income from operations
|
40,858
|
29,919
|
||||||
|
Investment income
|
1
|
—
|
||||||
|
Interest expense
|
1,208
|
1,296
|
||||||
|
Income before income taxes
|
39,651
|
28,623
|
||||||
|
Provision for income taxes
|
15,662
|
11,392
|
||||||
|
Net income
|
$
|
23,989
|
$
|
17,231
|
||||
|
Earnings per share:
|
||||||||
|
Basic
|
$
|
2.10
|
$
|
1.59
|
||||
|
Diluted
|
$
|
2.09
|
$
|
1.59
|
||||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
11,419
|
10,813
|
||||||
|
Diluted
|
11,477
|
10,850
|
||||||
|
For the three months
ended March 31,
|
||||||||
|
2012
|
2013
|
|||||||
|
Net income
|
$
|
23,989
|
$
|
17,231
|
||||
|
Other comprehensive income:
|
||||||||
|
Change in fair value of derivative instrument, net of income tax
|
(41
|
)
|
139
|
|||||
|
Comprehensive income
|
$
|
23,948
|
$
|
17,370
|
||||
|
Common Stock
|
Additional
Paid-in
|
Retained
|
Accumulated
Other
Comprehensive
|
|||||||||||||||||||||
|
Shares
|
Par Value
|
Capital
|
Earnings
|
Income (Loss)
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2011
|
11,792,456
|
$
|
118
|
$
|
295
|
$
|
42,491
|
$
|
(611
|
)
|
$
|
42,293
|
||||||||||||
|
Tax shortfall associated with stock-based compensation arrangements
|
—
|
—
|
(740
|
)
|
—
|
—
|
(740
|
)
|
||||||||||||||||
|
Restricted stock grants, net of forfeitures
|
71,484
|
1
|
(1
|
)
|
—
|
—
|
—
|
|||||||||||||||||
|
Stock-based compensation
|
—
|
—
|
2,390
|
—
|
—
|
2,390
|
||||||||||||||||||
|
Common stock dividends
|
—
|
—
|
—
|
(11,865
|
)
|
—
|
(11,865
|
)
|
||||||||||||||||
|
Change in fair value of derivative instrument, net of income tax
|
—
|
—
|
—
|
—
|
(41
|
)
|
(41
|
)
|
||||||||||||||||
|
Net income
|
—
|
—
|
—
|
23,989
|
—
|
23,989
|
||||||||||||||||||
|
Balance at March 31, 2012
|
11,863,940
|
$
|
119
|
$
|
1,944
|
$
|
54,615
|
$
|
(652
|
)
|
$
|
56,026
|
||||||||||||
|
Common Stock
|
Additional
Paid-in
|
Retained
|
Accumulated
Other
Comprehensive
|
|||||||||||||||||||||
|
Shares
|
Par Value
|
Capital
|
Earnings
|
Income (Loss)
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2012
|
11,387,299
|
$
|
114
|
$
|
299
|
$
|
41,311
|
$
|
(736
|
)
|
$
|
40,988
|
||||||||||||
|
Tax shortfall associated with stock-based compensation arrangements
|
—
|
—
|
(421
|
)
|
(2,865
|
)
|
—
|
(3,286
|
)
|
|||||||||||||||
|
Repurchase of common stock
|
(495,085
|
)
|
(5
|
)
|
(1,752
|
)
|
(23,242
|
)
|
—
|
(24,999
|
)
|
|||||||||||||
|
Restricted stock grants, net of forfeitures and conversions
|
(81,342
|
)
|
(1
|
)
|
1
|
—
|
—
|
—
|
||||||||||||||||
|
Stock-based compensation
|
—
|
—
|
2,250
|
— | — |
2,250
|
||||||||||||||||||
|
Change in fair value of derivative instrument, net of income tax
|
—
|
—
|
—
|
—
|
139
|
139
|
||||||||||||||||||
|
Net income
|
—
|
—
|
—
|
17,231
|
—
|
17,231
|
||||||||||||||||||
|
Balance at March 31, 2013
|
10,810,872
|
$
|
108
|
$
|
377
|
$
|
32,435
|
$
|
(597
|
)
|
$
|
32,323
|
||||||||||||
|
For the three months ended
March 31,
|
||||||||
|
2012
|
2013
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
23,989
|
$
|
17,231
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Amortization of gain on sale of assets
|
(70
|
)
|
(70
|
)
|
||||
|
Amortization of deferred rent
|
147
|
27
|
||||||
|
Amortization of deferred financing costs
|
200
|
195
|
||||||
|
Depreciation and amortization
|
5,817
|
6,190
|
||||||
|
Deferred income taxes
|
(317
|
)
|
(661
|
)
|
||||
|
Stock-based compensation
|
2,390
|
2,250
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Tuition receivable, net
|
1,686
|
1,081
|
||||||
|
Other current assets
|
(957
|
)
|
1,645
|
|||||
|
Other assets
|
(154
|
)
|
(4
|
)
|
||||
|
Accounts payable and accrued expenses
|
2,369
|
(8,220
|
)
|
|||||
|
Income taxes payable and income taxes receivable
|
15,443
|
11,847
|
||||||
|
Unearned tuition
|
(14,061
|
)
|
(265
|
)
|
||||
|
Other long-term liabilities
|
—
|
147
|
||||||
|
Net cash provided by operating activities
|
36,482
|
31,393
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property and equipment
|
(4,050
|
)
|
(2,368
|
)
|
||||
|
Net cash used in investing activities
|
(4,050
|
)
|
(2,368
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Repurchase of common stock
|
—
|
(24,999
|
)
|
|||||
|
Payments on term loan
|
(5,000
|
)
|
(781
|
)
|
||||
|
Payments on revolving credit facility
|
(20,000
|
)
|
—
|
|||||
|
Common dividends paid
|
(11,865
|
)
|
—
|
|||||
|
Net cash used in financing activities
|
(36,865
|
)
|
(25,780
|
)
|
||||
|
Net (decrease) increase in cash and cash equivalents
|
(4,433
|
)
|
3,245
|
|||||
|
Cash and cash equivalents – beginning of period
|
57,137
|
47,517
|
||||||
|
Cash and cash equivalents – end of period
|
$
|
52,704
|
$
|
50,762
|
||||
|
Non-cash transactions:
|
||||||||
|
Purchases of property and equipment included in accounts payable
|
$
|
1,225
|
$
|
706
|
||||
| 1. Nature of Operations |
| 2. Significant Accounting Policies |
|
●
|
Level 1 assets or liabilities use quoted prices in active markets for identical assets or liabilities as of the measurement date;
|
|
●
|
Level 2 assets or liabilities use observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities; and
|
|
●
|
Level 3 assets or liabilities use unobservable inputs that are supported by little or no market activity.
|
|
For the three months
ended March 31,
|
||||||||
|
2012
|
2013
|
|||||||
|
Weighted average shares outstanding used to compute basic earnings per share
|
11,419
|
10,813
|
||||||
|
Unvested restricted stock and restricted stock units
|
58
|
37
|
||||||
|
Shares used to compute diluted earnings per share
|
11,477
|
10,850
|
||||||
| 3. Term Loan and Revolving Credit Facility |
|
●
|
a total leverage ratio of not greater than 2.00:1.00;
|
|
●
|
a coverage ratio of not less than 1.75:1.00; and
|
|
●
|
a Department of Education financial composite score of not less than 1.5.
|
|
Term loan
|
$
|
124,219
|
||
|
Revolving credit facility
|
—
|
|||
|
Total debt
|
124,219
|
|||
|
Less: Current portion of long-term debt
|
3,125
|
|||
|
Long-term debt
|
$
|
121,094
|
|
2013
|
$
|
2,344
|
||
|
2014
|
3,125
|
|||
|
2015
|
6,250
|
|||
|
2016
|
112,500
|
|||
|
$
|
124,219
|
| 4. Fair Value Measurement |
|
Fair Value Measurements at Reporting Date Using
|
||||||||||||||||
|
March 31,
2013
|
Quoted Prices in
Active Markets for
Identical Assets/
Liabilities
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Cash equivalents:
|
||||||||||||||||
|
Money market funds
|
$
|
1,381
|
$
|
1,381
|
$
|
—
|
$
|
—
|
||||||||
|
Total assets at fair value on a recurring basis
|
$
|
1,381
|
$
|
1,381
|
$
|
—
|
$
|
—
|
||||||||
|
Liabilities:
|
||||||||||||||||
|
Other liabilities:
|
||||||||||||||||
|
Interest rate swaps
|
$
|
980
|
$
|
—
|
$
|
980
|
$
|
—
|
||||||||
|
Deferred payments
|
2,115
|
—
|
—
|
2,115
|
||||||||||||
|
Total liabilities at fair value on a recurring basis
|
$
|
3,095
|
$
|
—
|
$
|
980
|
$
|
2,115
|
||||||||
|
Fair Value Measurements at Reporting Date Using
|
||||||||||||||||
|
December 31,
2012
|
Quoted Prices in
Active Markets for
Identical Assets/
Liabilities
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Cash equivalents:
|
||||||||||||||||
|
Money market funds
|
$
|
1,380
|
$
|
1,380
|
$
|
—
|
$
|
—
|
||||||||
|
Total assets at fair value on a recurring basis
|
$
|
1,380
|
$
|
1,380
|
$
|
—
|
$
|
—
|
||||||||
|
Liabilities:
|
||||||||||||||||
|
Other liabilities:
|
||||||||||||||||
|
Interest rate swaps
|
$
|
1,211
|
$
|
—
|
$
|
1,211
|
$
|
—
|
||||||||
|
Deferred payments
|
2,119
|
—
|
—
|
2,119
|
||||||||||||
|
Total liabilities at fair value on a recurring basis
|
$
|
3,330
|
$
|
—
|
$
|
1,211
|
$
|
2,119
|
||||||||
|
●
|
Money market funds — Classified in Level 1 is excess cash the Company may hold in both taxable and tax-exempt money market funds and are included in cash and cash equivalents in the accompanying unaudited condensed consolidated balance sheets. The Company records any net unrealized gains and losses for changes in fair value as a component of accumulated other comprehensive income in stockholders’ equity. Realized gains and losses from the sale of marketable securities are based on the specific identification method. The Company’s remaining cash and cash equivalents held at December 31, 2012 and March 31, 2013, approximate fair value and is not disclosed in the above tables because of the short-term nature of the financial instruments.
|
|
●
|
Interest rate swaps — The Company has two interest rate swaps with a notional amount of $124.2 million as of March 31, 2013, used to minimize the interest rate exposure and fix the variable interest rate on a portion of the Company’s variable rate debt. The swaps are classified within Level 2 and are valued using readily available pricing sources which utilize market observable inputs including the current variable interest rate for similar types of instruments.
|
|
●
|
Deferred payments — The Company acquired certain assets and entered into a deferred payment arrangement with one of the sellers, which are classified within Level 3 as there is no liquid market for similarly priced instruments. The deferred payments are valued using a discounted cash flow model that encompassed significant unobservable inputs to estimate the operating results of the acquired assets. The assumptions used to prepare the discounted cash flows include estimates for interest rates, enrollment growth, retention rates and pricing strategies. These assumptions are subject to change as the underlying data sources evolve and the program matures.
|
|
Deferred
Payments
|
||||
|
Balance at December 31, 2012
|
$
|
2,119
|
||
|
Amounts earned
|
(65
|
)
|
||
|
Adjustments to fair value
|
61
|
|||
|
Transfers in or out of Level 3
|
—
|
|||
|
Balance at March 31, 2013
|
$
|
2,115
|
||
| 5. Stockholders’ Equity |
|
Number
of shares
or units
|
Weighted-
average grant
price
|
|||||||
|
Balance, December 31, 2012
|
434,439
|
$
|
178.88
|
|||||
|
Grants
|
165,712
|
$
|
62.28
|
|||||
|
Vested shares
|
(32,568
|
)
|
$
|
189.61
|
||||
|
Forfeitures
|
(47,054
|
)
|
$
|
215.71
|
||||
|
Balance, March 31, 2013
|
520,529
|
$
|
137.76
|
|||||
|
Number of
shares
|
Weighted-average exercise price
|
Weighted-average remaining
contractual
life (yrs.)
|
Aggregate intrinsic
value
(
¹
)
(in thousands)
|
|||||||||||||
|
Balance, December 31, 2012
|
100,000
|
$
|
107.28
|
0.1
|
$
|
—
|
||||||||||
|
Grants
|
100,000
|
51.95
|
||||||||||||||
|
Exercises
|
—
|
—
|
||||||||||||||
|
Forfeitures/Expirations
|
(100,000
|
)
|
107.28
|
|||||||||||||
|
Balance, March 31, 2013
|
100,000
|
$
|
51.95
|
7.8
|
$
|
—
|
||||||||||
|
Exercisable, March 31, 2013
|
—
|
$
|
—
|
—
|
—
|
|||||||||||
|
(1)
|
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the respective trading day and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holder had the options been exercised on the respective trading day. The amount of intrinsic value will change based on the fair market value of the Company’s common stock.
|
|
For the three months
ended March 31,
|
||||||||
|
2012
|
2013
|
|||||||
|
Instruction and educational support
|
$
|
671
|
$
|
1,097
|
||||
|
Marketing
|
—
|
—
|
||||||
|
Admissions advisory
|
—
|
—
|
||||||
|
General and administration
|
1,719
|
1,153
|
||||||
|
Stock-based compensation expense included in operating expense
|
2,390
|
2,250
|
||||||
|
Tax benefit
|
944
|
895
|
||||||
|
Stock-based compensation expense, net of tax
|
$
|
1,446
|
$
|
1,355
|
||||
| 6. Other Long-Term Liabilities |
|
2012
|
2013
|
|||||||
|
Deferred rent and other facility costs
|
$
|
11,650
|
$
|
11,901
|
||||
|
Deferred payments related to acquisition
|
4,919
|
4,915
|
||||||
|
Lease incentives
|
3,150
|
3,086
|
||||||
|
Deferred taxes
|
—
|
1,406
|
||||||
|
Fair value of interest rate swap (see Note 3)
|
1,211
|
980
|
||||||
|
Deferred gain on sale of campus building
|
975
|
905
|
||||||
|
$
|
21,905
|
$
|
23,193
|
|||||
| 7. Income Taxes |
| 8. Litigation |
| 9. Regulation |
|
Payments due by period (in thousands)
|
||||||||||||||||||||
|
Total
|
Within 1
Year
|
2-3
Years
|
4-5
Years
|
After 5
Years
|
||||||||||||||||
|
Operating leases
|
$
|
234,671
|
$
|
40,507
|
$
|
76,066
|
$
|
57,790
|
$
|
60,308
|
||||||||||
|
Term loan
|
124,219
|
3,125
|
10,156
|
110,938
|
—
|
|||||||||||||||
|
Total
|
$
|
358,890
|
$
|
43,632
|
$
|
86,222
|
$
|
168,728
|
$
|
60,308
|
||||||||||
| ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
| ITEM 4: CONTROLS AND PROCEDURES |
|
a)
|
Disclosure Controls and Procedures.
The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures as of March 31, 2013. Based upon such review, the Chief Executive Officer and Chief Financial Officer have concluded that the Company has in place, as of March 31, 2013, effective controls and procedures designed to ensure that information required to be disclosed by the Company (including its consolidated subsidiary) in the reports it files or submits under the Securities Exchange Act of 1934, as amended, and the rules thereunder, is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in reports it files or submits under the Securities Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
|
|
b)
|
Internal Control Over Financial Reporting
. There have not been any changes in the Company’s internal control over financial reporting during the quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
|
| Item 1. Legal Proceedings |
| Item 1A. Risk Factors |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
|
Total number of shares purchased
|
Average price paid per share
|
Total number of shares purchased as part of publicly announced plans or programs
|
Approximate dollar value of shares that may yet be purchased under the plans or programs ($ mil)
|
|||||||||||||
|
Beginning Balance (at 12/31/12)
|
$ | 95.0 | ||||||||||||||
|
January
|
29,975 | $ | 58.38 | 29,975 | $ | 93.2 | ||||||||||
|
February
|
115,390 | 51.98 | 115,390 | $ | 87.3 | |||||||||||
|
March
|
349,720 | 49.33 | 349,720 | $ | 70.0 | |||||||||||
|
Total (at 3/31/13)
|
495,085 | $ | 50.49 | 495,085 | $ | 70.0 | ||||||||||
|
(1)
|
The Company’s repurchase program was announced on November 3, 2003 for repurchases up to an aggregate amount of $15 million in value of common stock through December 31, 2004. The Board of Directors amended the program on various dates increasing the amount authorized and extending the expiration date, most recently on November 9, 2012 when the Board of Directors increased the amount authorized by an addition $100.0 million for 2012 and 2013.
|
| Item 3. Defaults Upon Senior Securities |
| Item 5. Other Information |
|
Nominee
|
Votes For
|
Votes Against
|
Abstain
|
Broker
Non-Vote
|
|
Robert S. Silberman
|
9,395,551 | 29,474 | 3,770 | 618,297 |
|
Robert R. Grusky
|
9,393,105 | 31,520 | 4,170 | 618,297 |
|
Dr. Charlotte F. Beason
|
9,393,077 | 31,697 | 4,021 | 618,297 |
|
William E. Brock
|
9,049,042 | 375,784 | 3,969 | 618,297 |
|
Dr. John T. Casteen, III
|
9,263,081 | 162,588 | 3,126 | 618,297 |
|
Robert L. Johnson
|
8,939,957 | 484,667 | 4,171 | 618,297 |
|
Karl McDonnell
|
9,389,368 | 35,803 | 3,624 | 618,297 |
|
Todd A. Milano
|
9,387,932 | 36,793 | 4,070 | 618,297 |
|
G. Thomas Waite, III
|
9,387,098 | 37,626 | 4,071 | 618,297 |
|
J. David Wargo
|
9,401,611 | 23,113 |
4,071
|
618,297 |
|
Votes For
|
Votes Against
|
Abstain
|
Broker
Non-Vote
|
| 10,015,261 | 28,430 | 3,401 | 0 |
|
Votes For
|
Votes Against
|
Abstain
|
Broker
Non-Vote
|
| 8,488,163 | 928,418 | 12,214 | 618,297 |
| Item 6. Exhibits |
|
STRAYER EDUCATION, INC.
|
|
|
By: /s/ Mark C. Brown
|
|
|
Mark C. Brown
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
Date: May 3, 2013
|
|
Exhibit
|
Description
|
|
|
10.1*†
|
Employment Agreement, dated as of May 2, 2013, between Strayer Education, Inc. and Robert S. Silberman.
|
|
|
10.2*†
|
Employment Agreement, dated as of May 2, 2013, between Strayer Education, Inc. and Karl McDonnell.
|
|
|
31.1
|
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Act.
|
|
|
31.2
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Act.
|
|
|
32.1
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101.
|
INS XBRL Instance Document
|
|
|
101.
|
SCH XBRL Schema Document
|
|
|
101.
|
CAL XBRL Calculation Linkbase Document
|
|
|
101.
|
DEF XBRL Definition Linkbase Document
|
|
|
101.
|
LAB XBRL Label Linkbase Document
|
|
|
101.
|
PRE XBRL Presentation Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|